Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Rating) has earned an average recommendation of “Hold” from the six ratings firms that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation and five have given a hold recommendation to the company. The average 1 year price objective among […]
Bank of America cut shares of Inovio Pharmaceuticals (NASDAQ:INO – Get Rating) from a neutral rating to an underperform rating in a research report sent to investors on Tuesday, Marketbeat Ratings reports. The brokerage currently has $2.00 price objective on the biopharmaceutical company’s stock. INO has been the topic of several other research reports. Royal […]
Inovio Pharmaceuticals (NASDAQ:INO – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday, Zacks.com reports. According to Zacks, “Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a […]
Zacks Investment Research downgraded shares of Inovio Pharmaceuticals (NASDAQ:INO – Get Rating) from a buy rating to a sell rating in a report released on Friday, Zacks.com reports. According to Zacks, “Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called […]